Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Net Sales	$ 1,818.1	$ 1,832.8	$ 5,749.8	$ 5,670.8
Cost of products sold, excluding intangible asset amortization	500.9	479.3	1,541.5	1,760.0
Intangible asset amortization	152.7	164.3	452.4	424.7
Research and development	91.2	95.6	272.4	269.9
Selling, general and administrative	694.5	727.7	2,203.3	2,176.6
Special items (Note 2)	165.4	170.4	434.1	397.0
Operating expenses	1,604.7	1,637.3	4,903.7	5,028.2
Operating Profit	213.4	195.5	846.1	642.6
Other expense, net	(4.5)	(1.1)	(11.2)	(8.7)
Interest income	0.6	0.6	1.4	2.7
Interest expense	(82.3)	(91.5)	(247.5)	(267.8)
Earnings before income taxes	127.2	103.5	588.8	368.8
Provision (benefit) for income taxes	28.4	(54.4)	6.6	133.9
Net Earnings	98.8	157.9	582.2	234.9
Less: Net loss attributable to noncontrolling interest		(0.9)	(0.2)	(1.4)
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 98.8	$ 158.8	$ 582.4	$ 236.3
Earnings Per Common Share
Basic	$ 0.49	$ 0.79	$ 2.89	$ 1.18
Diluted	$ 0.48	$ 0.78	$ 2.86	$ 1.17
Weighted Average Common Shares Outstanding
Basic	202.3	200.1	201.7	199.9
Diluted	204.0	202.9	203.6	202.3
Cash Dividends Declared Per Common Share	$ 0.24	$ 0.24	$ 0.72	$ 0.72